Skeletal Muscle Delimited Myopathy and Verapamil Toxicity in SUR2 Mutant Mouse Models of AIMS [PDF]
Abstract ABCC9 ‐related intellectual disability and myopathy syndrome (AIMS) arises from loss‐of‐function (LoF) mutations in the ABCC9 gene, which encodes the SUR2 subunit of ATP‐sensitive potassium (K ATP ...
Anamika Dayal +2 more
exaly +6 more sources
Involvement of SUR2/Kir6.1 Channel in the Physiopathology of Pulmonary Arterial Hypertension
AimsWe hypothesized that the ATP-sensitive K+ channels (KATP) regulatory subunit (ABCC9) contributes to PAH pathogenesis. ABCC9 gene encodes for two regulatory subunits of KATP channels: the SUR2A and SUR2B proteins. In the KATP channel, the SUR2 subunits are associated with the K+ channel Kir6.1. We investigated how the SUR2/Kir6.1 channel contributes
Mary Dutheil
exaly +5 more sources
Structural Identification of Vasodilator Binding Sites on the SUR2 Subunit
Abstract ATP-sensitive potassium channels (K ATP ), composed of Kir6 and SUR subunits, convert the metabolic status of the cell into electrical signals. Pharmacological activation of SUR2- containing K ATP channels by class of small ...
Jing-Xiang Wu, Lei Chen
exaly +4 more sources
Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome [PDF]
(1) Background: Cantu syndrome (CS) arises from gain-of-function (GOF) mutations in the ABCC9 and KCNJ8 genes, which encode ATP-sensitive K+ (KATP) channel subunits SUR2 and Kir6.1, respectively. Most CS patients have mutations in SUR2, the major component of skeletal muscle KATP, but the consequences of SUR2 GOF in skeletal muscle are unknown.
Conor McClenaghan +2 more
exaly +5 more sources
Complex Consequences of Cantu Syndrome SUR2 Variant R1154Q in Genetically Modified Mice [PDF]
Cantu syndrome (CS) is caused by gain-of-function (GOF) mutations in pore-forming (Kir6.1, KCNJ8 ) and accessory (SUR2, ABCC9 ) ATP-sensitive potassium (K ATP ) channel subunits, the most common mutations being ...
Eric C Arakel +2 more
exaly +6 more sources
Characterization of four structurally diverse inhibitors of SUR2-containing K<sub>ATP</sub> channels. [PDF]
Vascular smooth muscle ATP-sensitive potassium (KATP) channels play critical roles in modulating vascular tone and thus represent important drug targets for diverse cardiovascular pathologies. Despite extensive research efforts spanning several decades, the search for selective inhibitors that can discriminate between vascular KATP (i.e.
Li K, Satpute Janve V, Denton J.
europepmc +4 more sources
Muscle fatigue arising intrinsically from SUR2- but not Kir6.1-dependent gain-of-function in Cantu syndrome mice. [PDF]
Cantu syndrome (CS) is a rare disease caused by gain-of-function (GOF) mutations of Kir6.1 or SUR2 subunits of ATP-sensitive potassium (KATP) channels. CS patients with SUR2 and Kir6.1 variants display a similar constellation of symptoms, including muscle weakness and fatigue.
Scala R +7 more
europepmc +4 more sources
Alternative Splicing of sur2 Exon 17 Regulates Nucleotide Sensitivity of the ATP-Sensitive Potassium Channel [PDF]
ATP-sensitive potassium channels (KATP) are implicated in a diverse array of physiological functions. Previous work has shown that alternative usage of exons 14, 39, and 40 of the muscle-specific KATP channel regulatory subunit, sur2, occurs in tissue-specific patterns.
Charles F. Burant +2 more
exaly +3 more sources
The ABCC9 gene and its polypeptide product, SUR2, are increasingly implicated in human neurologic disease, including prevalent diseases of the aged brain. SUR2 proteins are a component of the ATP-sensitive potassium ("KATP") channel, a metabolic sensor for stress and/or hypoxia that has been shown to change in aging.
Colin Nichols +2 more
exaly +4 more sources
Cantu syndrome-associated SUR2[H60Y] mutation confers selective gain of function on Kir6.1 ATP-sensitive potassium channels. [PDF]
Gain-of-function (GOF) mutations in either Kir6.1 (encoded by KCNJ8) or SUR2 (encoded by ABCC9) are causally associated with Cantu syndrome (CS), characterized by coarse facial appearance, hypertrichosis, and multiple cardiovascular abnormalities. To date, all SUR2 mutations identified in association with CS have demonstrated GOF because of reduced ATP
Gao J, Thompson ET, Nichols CG.
europepmc +3 more sources

